GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (STU:LWA) » Definitions » Float Percentage Of Total Shares Outstanding

Eco Animal Health Group (STU:LWA) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jan. 19, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Eco Animal Health Group Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eco Animal Health Group's float shares is 0.00 Mil. Eco Animal Health Group's total shares outstanding is 67.76 Mil. Eco Animal Health Group's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eco Animal Health Group's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eco Animal Health Group's Institutional Ownership is 40.41%.


Eco Animal Health Group Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Eco Animal Health Group's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/67.76
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eco Animal Health Group Business Description

Industry
Traded in Other Exchanges
Address
100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.

Eco Animal Health Group Headlines

No Headlines